Latest News

Quanergy Completes Series C Financing with a Valuation Surpassing $2 Billion

MegaPro Biomedical was invited to “The Third China BioMed Innovation and Investment Conference” hosted by PhIRDA

Apexigen Raises $73 Million In Series B and Series C Financings

Apexigen and Yale Cancer Center Announce Clinical Collaboration to Evaluate APX005M, Cabiralizumab, and Opdivo (Nivolumab) in Patients whose Disease has Progressed on Anti-PD-1/PD-L1 Therapy

Quanergy Wins Silicon Valley Chamber of Commerce Annual Murphy Award

MegaPro, Outstanding performance from MegaPro Biomedical, the contrast agent has received approval by FDA for Phase II of clinical trial

Apexigen Announces New Collaboration with UCSF

Minth Is First Parts Maker to Win China Electric Car Permit

Sitemap

Contact Us
  • +886-2-2325-8218
© 2020 Trans-Pacific Technology. Fund All Rights Reserved.